Skip to main content

Table 2 Multivariate analysis of different prognostic factors in all stages and stage I ADC patients (two groups)

From: SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients

ADC type Variable Comparison Hazard ratio (95% CI) P value
All stages ADC patients (n = 275) Age 20–84 years 1.057 (1.025–1.090) 0.000
Gender Male; Female 1.581 (0.789–3.169) 0.196
Histological grade Grade 1–3 1.107 (0.712–1.722) 0.652
Tumor diameter 0.8–8 cm 0.973 (0.788–1.201) 0.796
Lymph node no 0–15 1. 014 (0.939–1.096) 0.720
Clinical stage Stage I- IV 2.605 (1.852–3.663) 0.000
Tumor location Left; Right 0.535 (0.298–0.960) 0.036
SOX30 expression High; Low 0.874 (0.807–0.946) 0.001
Stage I ADC patients (n = 112) Age 20–84 years 1.109 (1.011–1.216) 0.028
Gender Male; Female 1.182 (0.155–9.002) 0.872
Histological grade Grade 1; 2; 3 4. 702 (0.586–37.737) 0.145
Tumor diameter 0.8-7 cm 0.954 (0.402–2.268) 0.916
Tumor location Left; Right 2. 605 (0.642–10.572) 0.180
SOX30 expression High; Low 0.726 (0.567–0.929) 0.011
  1. Cox regression analysis was used to test independent prognostic contributions
  2. CI represents confidence interval. The p < 0.05 was considered statistically significant
  3. The entries in boldface indicate statistically significant